Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1241-1250 of 2905 for cancer

Edit search filters
  1. Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

    Rochester, MN

  2. IS-002 In Prostate Cancer

    Rochester, MN

  3. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma

    Rochester, MN

  4. A Study To Evaluate The Safety Of Lasofoxifene In Combination With Abemaciclib In Advanced Or Metastatic ER+/HER2− Breast Cancer With ESR1 Mutation

    Jacksonville, FL, Rochester, MN

  5. Romidepsin in Treating Patients with Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors with Liver Dysfunction

    Rochester, MN

  6. A Study To Compare Elacestrant Vs. Standard Of Care For The Treatment Of Patients With ER+/HER2- Advanced Breast Cancer

    Rochester, MN

  7. A Study Of Pertuzumab In Addition To Chemotherapy And Herceptin (Trastuzumab) As Adjuvant Therapy In Patients With HER2-Positive Primary Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. A Study To Evaluate The Diagnostic Potential Of A Lateral Flow Assay To Detect QSOX1 Peptide In Patients With Or At Risk For Pancreatic Cancer

    Scottsdale/Phoenix, AZ

  9. Bortezomib, Rituximab, and Dexamethasone with or without Temsirolimus in Treating Patients with Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma

    Rochester, MN

  10. A Study To Evaluate The Safety And Effectiveness Of Hypofractionation Proton Beam Therapy In Patients With Clinically Localized, Intermediate, Or High Risk Prostate Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer